 
                        | Product NDC: | 55154-2879 | 
| Proprietary Name: | Midazolam | 
| Non Proprietary Name: | Midazolam | 
| Active Ingredient(s): | 5 mg/mL & nbsp; Midazolam | 
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55154-2879 | 
| Labeler Name: | Cardinal Health | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075243 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20000620 | 
| Package NDC: | 55154-2879-8 | 
| Package Description: | 1 VIAL in 1 BAG (55154-2879-8) > 10 mL in 1 VIAL | 
| NDC Code | 55154-2879-8 | 
| Proprietary Name | Midazolam | 
| Package Description | 1 VIAL in 1 BAG (55154-2879-8) > 10 mL in 1 VIAL | 
| Product NDC | 55154-2879 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Midazolam | 
| Dosage Form Name | INJECTION | 
| Route Name | INTRAMUSCULAR; INTRAVENOUS | 
| Start Marketing Date | 20000620 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Cardinal Health | 
| Substance Name | MIDAZOLAM HYDROCHLORIDE | 
| Strength Number | 5 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |